Table 1 Maximum scores and items for each section in the questionnaires assessing quality of the research in case–control and cohort studies.
| Questionnaire sections | Design | ||
|---|---|---|---|
| Case–control | Prospective cohort | Retrospective cohort | |
| Definition and follow‐up of the cohort | |||
| Maximum score | NA | 11 | 18 |
| Items | NA | 1–7 | 1–8 |
| Losses to follow‐up | |||
| Maximum score | NA | 13 | 11 |
| Items | NA | 8–12 | 9–12 |
| Measurement of disease incidence | |||
| Maximum score | NA | 6 | 5 |
| Items | NA | 13–16 | 13–15 |
| Selection of the cases and controls | |||
| Maximum score | 25 | NA | NA |
| Items | 1–11 | NA | NA |
| Inclusion and exclusion criteria for cases and controls | |||
| Maximum score | 9 | NA | NA |
| Items | 12–16 | NA | NA |
| Occupational exposure measurement | |||
| Maximum score | 18 | 9 | 8 |
| Items | 17–28 | 17–20 | 16–18 |
| Control of confounding variables | |||
| Maximum score | 9 | 9 | 9 |
| Items | 29, 30 | 21, 22 | 21, 22 |
| Precision | |||
| Maximum score | 2 | 2 | 2 |
| Items | 31, 32 | 23, 24 | 23, 24 |
| Internal and external validity | |||
| Maximum score | 8 | 8 | 8 |
| Items | 33, 34 | 25, 26 | 25, 26 |
| Likelihood for biases | |||
| Maximum score | 40 | 32 | 32 |
| Items | 35–39 | 27–30 | 27–30 |
| Global Quality Index* | |||
| Maximum score | 111 | 90 | 93 |
NA, not applicable.
*In the text the Global Quality Index (GQI) for each study is presented as a percentage of these maximum scores.